The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine- like in rhesus monkeys

PM Beardsley, BA Hayes and RL Balster

Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0613.

The proposed noncompetitive N-methyl-D-aspartate antagonist MK-801 [(+)- 5-methyl-10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5,10-imine maleate] has therapeutic potential as an anticonvulsant and neuroprotectant. Previous research has demonstrated that MK-801 shares many of the biochemical and pharmacological actions of the abused drug phencyclidine (PCP). The purpose of the present study was to determine whether rhesus monkeys would self-administer i.v. MK-801 and to determine whether MK-801 has discriminative stimulus properties similar to those of PCP. Four Rhesus monkeys were trained to press response levers according to fixed-ratio 10 schedules of reinforcement for infusions of cocaine (33 micrograms/kg/injection) or PCP (10 micrograms/kg/injection). Various doses of MK-801 were evaluated during substitution tests to determine whether they would maintain lever pressing. None of the four rhesus monkeys tested self-administered MK- 801 when it was offered to them after a recent history of cocaine self- administration. Three of the four monkeys, however, did self-administer MK-801 when provided a history of PCP self-administration. All four rhesus monkeys given drug discrimination training with 80 micrograms/kg PCP and tested with MK-801 generalized from the PCP stimulus in a dose- dependent manner. MK-801 was about 2 to 3 times more potent and had a longer duration of action than PCP. Overall, these results provide further evidence in a primate species of similarities in the behavioral effects of MK-801 and PCP, and suggest that MK-801 may have abuse potential of the PCP type.

Volume 252, Issue 3, pp. 953-959, 03/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				G. T. Collins and J. H. Woods Drug and Reinforcement History as Determinants of the Response-Maintaining Effects of Quinpirole in the Rat J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 599 - 605. [Abstract] [Full Text] [PDF]

				E. R. Butelman, J. W. Ball, T. J. Harris, and M. J. Kreek Topical Capsaicin-Induced Allodynia in Unanesthetized Primates: Pharmacological Modulation J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1106 - 1114. [Abstract] [Full Text] [PDF]

				G. Winger, S. R. Hursh, K. L. Casey, and J. H. Woods Relative Reinforcing Strength of Three N-Methyl-D-Aspartate Antagonists with Different Onsets of Action J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 690 - 697. [Abstract] [Full Text] [PDF]